Successful eradication of chronic myeloid leukemia in a child despite allogeneic graft rejection
Abstract Background Chronic myeloid leukemia (CML) is a rare disease in children and treated with tyrosine kinase inhibitors (TKI) and with allogeneic hematopoietic stem cell transplantation (HSCT) still in many cases. Case We describe an 8‐year‐old patient with CML treated with two different TKIs b...
Main Authors: | Susanna Vuorenoja, Kim Vettenranta, Olli Lohi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1663 |
Similar Items
-
Update in Childhood Chronic Myeloid Leukemia
by: Fiorina Giona, et al.
Published: (2022-11-01) -
Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report
by: Nuno Cerveira, et al.
Published: (2018-12-01) -
Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
by: Asim Saha, et al.
Published: (2022-10-01) -
Immunopathogenesis of corneal graft rejection
by: Prafulla Kumar Maharana, et al.
Published: (2023-01-01) -
Management and prevention of corneal graft rejection
by: Sohini Mandal, et al.
Published: (2023-01-01)